NAMA
CAI

Nikko Asset Management Americas’s Caris Life Sciences CAI Stock Holding History

Nikko Asset Management Americas’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$646K Sell
36,133
-18,586
-34% -$406K 0.01% 173
2025
Q4 		$1.48M Buy
54,719
+7,348
+16% +$207K 0.02% 145
2025
Q3 		$1.43M Buy
+47,371
New +$1.51M 0.01% 141

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $326M AUM
SSP
Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Nikko Asset Management Americas's CAI Position: Q1 2026 in Review

Nikko Asset Management Americas reduced its Caris Life Sciences (CAI) stake by 34% in Q1 2026, selling an estimated $406K and leaving 36,133 shares worth $646K. The position accounts for 0.01% of the portfolio, ranked #173.

Nikko Asset Management Americas first reported a position in CAI in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.48M in Q4 2025. 202 funds tracked by Wall St. Rank hold CAI as of Q1 2026.

  • Nikko Asset Management Americas held 36,133 shares of Caris Life Sciences worth $646K as of Q1 2026.
  • Nikko Asset Management Americas sold 18,586 Caris Life Sciences shares in Q1 2026, an estimated $406K.
  • Caris Life Sciences made up 0.01% of Nikko Asset Management Americas's portfolio in Q1 2026, its #173 holding.
  • Nikko Asset Management Americas first reported a position in Caris Life Sciences in Q3 2025 and has held it in 3 quarters since.
  • Nikko Asset Management Americas's Caris Life Sciences position peaked at $1.48M in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Caris Life Sciences as of Q1 2026.

Based on Nikko Asset Management Americas's 13F filing for Q1 2026, filed 7 May 2026.